Jin Xu

156 papers receiving 3.0k citations

Peers

Jin Xu
Comparison fields: 5 of 156
  • Health, Toxicology and Mutagenesis 362
  • Developmental Neuroscience 99
  • Cancer Research 309
  • Environmental Chemistry 165
  • Molecular Biology 1.0k
Replace Huimei Chen with:
Huimei Chen China
Dongmei Wu China
Wei Hu China
Su Liu China
Karen Bedard Canada
Hisashi Yamada Japan
Xia Qin China
Federico M. Farin United States
Xuejun Jiang China
Jin Xu relative to Huimei Chen China Huimei Chen's profile →
Citations per field
00.5×1.5×2.2×
Huimei Chen · 1×
Citations per year

Countries citing papers authored by Jin Xu

Since Specialization
Citations

This map shows the geographic impact of Jin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Xu more than expected).

Fields of papers citing papers by Jin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Xu. The network helps show where Jin Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Jin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jin Xu Line = papers co-authored together Jin Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20250
4 20250
5 20250
6 20250
7 20242
8 20241
9 20234
10 20236
11 20232
12 20222
13 202024
14 20191
15 201554
16
Bax inhibitor-1 is overexpressed in non-small cell lung cancer and promotes its progression and metastasis.
201519
17 201347
18
Photoreceptor outer segment phagocytosis couples lysosome biogenesis to autophagy in the retinal pigment epithelium
20131
19 201230
20 200699

About Jin Xu

Jin Xu is a scholar working on Endocrine and Autonomic Systems, Developmental Neuroscience, Obstetrics and Gynecology, Cancer Research and Anesthesiology and Pain Medicine, having authored 171 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Birth, Development, and Health (8 papers), Genetic Associations and Epidemiology (7 papers), Pregnancy and preeclampsia studies (7 papers), Circadian rhythm and melatonin (6 papers), MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (6 papers) and Hormonal Regulation and Hypertension (6 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (362 citations), Developmental Neuroscience (99 citations), Cancer Research (309 citations), Environmental Chemistry (165 citations) and Molecular Biology (1.0k citations). Jin Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lindan Ji, Lihong Xu, Mi Zhou, Xiaofeng Wang, Chen Wu, Wenyu Fu, Kevin Shannon, Jinshun Zhao, Jia Su and Lingling Fu. Their work appears in journals such as PLoS ONE, Environmental Toxicology, Toxicon, BioMed Research International and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026